Perjeta (Pertuzumab) Drug Interactions: 63 Moderate
Perjeta (Pertuzumab) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Perjeta. Always confirm against the full prescribing information.
100 interactions
Anastrozole
The risk or severity of cardiotoxicity can be increased when Anastrozole is combined with Pertuzumab.
Level 2 evidence
Arsenic trioxide
The risk or severity of cardiotoxicity can be increased when Arsenic trioxide is combined with Pertuzumab.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Pertuzumab is combined with Articaine.
Level 1 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Pertuzumab is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Pertuzumab is combined with Benzyl alcohol.
Level 1 evidence
Bevacizumab
The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Pertuzumab.
Level 2 evidence
Bleomycin
The risk or severity of cardiotoxicity can be increased when Bleomycin is combined with Pertuzumab.
Level 2 evidence
Bortezomib
The risk or severity of cardiotoxicity can be increased when Bortezomib is combined with Pertuzumab.
Level 2 evidence
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Pertuzumab is combined with Bupivacaine.
Level 1 evidence
Busulfan
The risk or severity of cardiotoxicity can be increased when Busulfan is combined with Pertuzumab.
Level 2 evidence
Butamben
The risk or severity of methemoglobinemia can be increased when Pertuzumab is combined with Butamben.
Level 1 evidence
Cabazitaxel
The risk or severity of cardiotoxicity can be increased when Pertuzumab is combined with Cabazitaxel.
Perjeta (Pertuzumab) has 224 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Perjeta (Pertuzumab) has 0 major, 63 moderate, and 161 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Perjeta. Always confirm against the full prescribing information.